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Abstract
Cognitive impairment is one of the predominant diagnoses that in its early stages remain
undetected in the primary healthcare setting. With Alzheimer's and dementia on the rise,
it is paramount that cognitive impairment be detected promptly so preventative measures
may be initiated to slow or avert progression of this dreaded disease. The annual
wellness visit, a Medicare benefit added by the Affordable Care Act o f 2010,
recommends primary care providers conduct a screening to detect cognitive impairment
during the course o f this assessment. The Centers for Medicare and Medicaid services
failed to recommend a specific screening tool to be utilized by primary care providers to
detect cognitive impairment. The Medicare Detection o f Cognitive Impairment
Workgroup convened by the Alzheimer’s Association, conducted research on this
subject, and found that the General Practitioner Assessment o f Cognition (GPCOG), the
Mini-Cog, and the Memory Impairment Screen (MIS) are brief structured tools that
would be suitable for cognitive assessment function during the annual wellness visit. The

goal for this study was to evaluate 600 charts (100 from each primary care provider’s
office) to determine if cognitive impairment screening was being conducted during the
Medicare annual wellness visit. If the screening was being performed, further assessment
was conducted to determine if a recommended screening tool was utilized by the
provider. The researchers have hypothesized that cognitive impairment screening is not
taking place according to the prescribed recommendations.
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CHAPTER I
Dimensions of the Problem
Cognitive impairment goes unrecognized in a large number o f patients under the
care of primary care providers. Delayed or missed diagnosis deprives affected
individuals of available treatments and services that may help to improve their symptoms
and help them maintain their independence (Cordell et al., 2013).
Alzheimer’s disease is the 5th leading cause o f death among adults in the United
States (U.S.) between 65 and 85 years o f age, and death rates for Alzheimer’s diseases
are increasing— unlike death rates o f other diseases such as cancer and heart disease
which are on the decline (Centers for Disease and Prevention [CDC], 2016). Part o f this
growing problem is that cognitive impairment goes unrecognized in 27% to 81% of
affected patients in primary care (Cordell et al., 2013). In 2013, around 5 million
Americans were living with Alzheimer’s disease; by 2050 it is projected that this number
will rise to 14 million (CDC, 2016). The annual wellness visit, a Medicare benefit added
by the Affordable Care Act o f 2010, recommends primary care providers conduct an
assessment to detect cognitive impairment (Cordell et al., 2013). The Centers for
Medicare and Medicaid services did not recommend a specific assessment tool to be used
by primary care providers to detect cognitive impairment. The Medicare Detection of
Cognitive Impairment Workgroup convened by the Alzheimer’s Association conducted
research on this subject and found that the GPCOG, Mini-Cog, and MIS are brief
structured tools that would be suitable for cognitive assessment function during the
annual wellness visit (Cordell et al., 2013). Thus, the problem addressed in this study
was the cognitive impairment screening practices o f primary care providers in
Mississippi.

As America’s population ages, the prevention of age-related diseases, such as
Alzheimer’s and dementia, becomes paramount. Therefore, this study determined
whether primary care providers are adhering to the national guidelines related to the
screening o f patients for cognitive impairment. If the screening process and procedures
used by primary care providers in Mississippi related to cognitive impairment are found
to be subpar, measures can be put into place to improve the screening process, which in
turn will improve the lives of Mississippi’s aging population.
Purpose of the Research
The purpose of this study was to determine whether primary care providers are
following the recommendations related to cognitive impairment screening during an
annual wellness visit put into place by the Patient Protection and Affordable Care Act of
2010 effective January 1, 2011.
Significance of the Research
By determining if healthcare providers are adhering to the recommendations
related to screening for cognitive impairment, the current researchers will disclose if
there is a lack o f knowledge and awareness on the subject indicating the need for
education of primary care providers. Prevention o f disease and illness is one o f the most
important aspects o f healthcare and a principal duty of healthcare providers. If detected
in the early stages, mild cognitive impairment can be slowed by various interventions.
Interventions, such as management o f comorbidities and medications including N amenda
and Aricept, can aid in slowing the progression from mild cognitive impairment to
dementia and Alzheimer’s.
Oftentimes without proper screening of the early stage of cognitive decline, mild
cognitive impairment goes undetected and the patient’s memory impairment is not

detected until it has progressed to dementia or Alzheimer’s disease. With sound
screening practices, early detection of cognitive impairment is possible and in turn will
result in more positive outcomes for patients and hopefully will decrease the prevalence
of detrimental diseases such as dementia and Alzheimer’s.
Conceptual Framework
Healthcare providers can and should be present within the interpersonal
environment o f the client. One way of becoming personally involved with clients is to
monitor for changes in health status with the use of screening tools. The purpose of
medical screening is for the early detection o f disease so that measures can be taken to
prevent further decline or recognize the need for close observation as well as taking into
consideration the safety o f the patients. Nola Pender’s Health Promotion Model (HPM)
was used as a guide in this study to determine if primary care providers are following the
guidelines related to cognitive impairment screening during an annual wellness visit.
Screening for cognitive impairment, dementia, and Alzheimer’s has become paramount
due to the aging population o f America. Early recognition of cognitive impairment
through screening can assist the nurse practitioner (NP) in developing a care plan to treat
early symptoms and possibly slow down or delay further decline. Drawing upon the
concepts and constructs of the HPM, the researchers will be able to use a more holistic
approach in caring for clients. Personal factors, such as age and self-motivation, help
predict healthcare behaviors and willingness to participate in a personal health promotion
plan. Recognizing perceived barriers such as fear of losing independence is important
when promoting the early recognition o f cognitive decline. The HPM assumes that
healthcare professionals are part o f the client’s interpersonal environment and can
influence the client throughout their life. Illuminating the need for cognitive impairment

screening each year during an annual wellness visit and applying education based on the
HPM will assist our patients in overcoming perceived barriers related to a diagnosis of
cognitive impairment and dementia.
Research Questions and Hypothesis
The following questions were developed to guide the research and data gathering.
1. During annual wellness visits, are primary care providers screening Medicare
Patients 65 years and older to detect cognitive impairment?
2. During the cognitive impairment screening, are primary care providers using
one of the three validated patient assessment tools: the General Practitioner
Assessment o f Cognition (GPCOG), the Memory Impairment Screen (MIS),
Mini-Mental State Exam (MMSE), or the Mini-Cog when cognitive
impairment screening is performed? If none o f the above, which assessment
tool are they using?
3. What interventions are put into place for patients who show a decline in
cognition on these screening tools?
The research hypothesis was as follows: Primary care providers are not screening
Medicare patients 65 years and older for cognitive impairment during an annual wellness
exam.
Definition of Terms
There were various terms regarding research that require a definition to clarify
their meaning in relation to the current study. The theoretical and operational definitions
respectively follow:

Primary care provider
Theoretical: The health care provider to whom a patient first goes to address a
problem with his or her health. (Venes, 2013)
Operational: Medieal eare provider performing the wellness exam.
Cognitive impairment
Theoretical: When a person has trouble remembering, learning new things,
concentrating, or making decisions that affect their everyday life. (CDC, 2010)
Operational: Impairment o f an individual’s mental function or capacity based on
cognitive testing results.
Annual wellness visit
Theoretical: A physical exam performed by a primary eare provider once every
12 months.
Operational: A yearly physical exam performed by a primary eare provider for
people over the age o f 65 years that is free to the patient and paid by Medicare.
Cognitive impairment screening
Theoretical: Screening for altered mental status thought process.
Operational: Screening for altered mental thought processes by the following
tools: GPCOG, MIS, Mini-Cog, and Mini-Mental State Exam (MMSE).
Interventions
Theoretical: An action taken to enhance a situation such as a medical disorder.
Operational: An action taken to improve a medieal disorder, such as the
following: neurological referral, social services referral, medications for dementia, and
psychosocial work-up.
Assumptions

For the purpose of this study, the following assumptions were made:
1. The researchers assumed primary eare providers are aware of guidelines to
perform cognitive screening at Medicare annual wellness exams to all patients
65 years and older.
2. The researchers assumed cognitive screening tools are adequate measures of a
person’s cognitive function.

CHAPTER II
Literature Review
The researchers presented a review of literature which included research articles
that examined Nola Pender’s Health Promotion Model (HPM). Data that supported the
findings applicable to the current study o f cognitive impairment screening practices were
also included in the review of literature. To gain perception for the current study, the
researchers reviewed Nola Pender’s work to help give insight o f the HPM.
Literature Related to Conceptual Framework
The role of the nurse practitioner has evolved since the time o f inception in the
1960s. Rural communities continue to desire the eare and attention afforded by nurse
practitioners and their availability to provide healthcare within reach of those who would
otherwise lack access to convenient and affordable medieal care (Keeling, 2015). Nurse
practitioners are involved in promoting and maintaining healthy lifestyles and preventing
disease and, therefore, need to understand the influences that can hinder health promotion
in order to motivate their patients to adhere to management programs. Health promotion
is a process of being proactive in the preservation o f the health and well-being o f patients
and society. The HPM, developed by Nola Pender in the 1980s, assists the NP with
several areas o f health promotion. The model gives nurses a structural format o f
definitions and concepts that can help design health promotion strategies. Use o f this
theoretical framework helps predict how certain behaviors and practices can have an
influence on health outcomes.
Studies on illness prevention and health promotion have been a focus o f research
for many years. In a eross-seetional survey of 388 residents of northern Illinois
performed in 1978, it was shown that 64% of those surveyed indicated interest in using

an illness prevention and health promotion service if provided by a nurse practitioner.
The results o f the study showed a high level of acceptance o f nurse practitioners and
indicated the need within the community for nurse practitioners to provide prevention and
health promotion centered eare (Pender & Pender, 1980). According to Pender, health
promotion is a goal for today’s healthcare just as disease prevention was a component of
healthcare before the 20th century. Pender believes the patient should play an active role
in managing his or her health by desiring to change or alter certain lifestyles that may
contribute to disease. Nola Pender’s view also included the concept that past behavior,
cultural traditions, and family traditions can impact a person's ability to engage in healthpromoting behaviors. Pender’s HPM provides healthcare providers with a tool that helps
them understand how the consumer can be motivated to attain better health (Alligood,
2014).
Promoting healthy behaviors is part of the nurse practitioner’s role while earing
for clients. Self-efficacy is the belief that one has in oneself to accomplish a goal. A
perceived benefit is an anticipated positive outcome which a client believes will result
from a health behavior. Educating clients using Pender’s HPM can result in increased
self-efficaey and perceived benefit with subsequent increase in positive affect. Dehdari,
Rahimi, Aryaeian, and Gohari (2013) conducted a quasi-experimental study based on
Pender’s Health Promotion Model in 2011 to determine the effectiveness of nutrition
education interventions in improving the frequency and nutrient intake o f breakfast
consumption among female students. The constructs o f Pender’s model were used to
develop a questionnaire that included questions related to prior behaviors, perceived selfefficaey, and perceived barriers to name a few. Perceived barriers can be either imagined
or actual blocks and personal costs related to taking part in certain behaviors. A Likert

rating scale was used to record answers. The results of the questionnaire were then used
to design a nutrition education intervention. Usual classroom nutrition education was
provided to each o f two groups: an experimental group and a control group. The
experimental group received extra nutritional education based on Pender’s HPM. Results
of the study indicated that the experimental group had increases in perceived benefit and
self-effieaey. Perceived barriers and negative activity-related affect were decreased as
well in the experimental group. Increasing perceived self-efficacy results in having fewer
perceived barriers in performing certain healthcare behaviors, thus changing the client’s
perceptions on health behaviors and leading to positive changes (Dehdari et al., 2013).
Managing chronic disease is another important role of the nurse practitioner. The
NP uses theory in everyday practice while applying knowledge, education, and skills to
promote the health of his or her clients. One o f the most common chronic diseases that
NPs manage is hypertension. As a significant health concern, hypertension is the leading
risk factor for heart disease, stroke, and renal disease. Lifestyle modifications, including
diet changes, weight management, increasing physical activity and managing stress, will
help control hypertension and prevent long-term complications. Hussein, Salam, and
Amr (2016) utilized a quasi-experimental study to assess the management o f
hypertension using the Pender’s HPM. The model was used because it focuses on the
relationship between individual eharaeteristics and experiences, behavior specific
cognitions, and behavioral outcomes. Another reason the model was used is the
assumption that people are active in maintaining healthy behaviors and are willing to
change their environment to support these behaviors. The study was divided into a study
group and a control group. Results o f the study indicated that nursing education
interventions were successful in improving knowledge, lifestyle behaviors, and

measurements in blood pressure among the adults whieh were in the study group as
opposed to the control group (Hussein et al., 2016).
Healthcare providers can and should be present within the interpersonal
environment o f the client. One way o f becoming personally involved with clients is to
monitor for changes in health status with the use o f screening tools. The purpose of
medical screening is early detection o f disease so that measures can be taken to prevent
further decline or recognize the need for close observation as well as taking into
consideration the safety o f the patients. Pender’s HPM was used as a guide in a study
that proposed to determine if primary care providers are following the guidelines related
to cognitive impairment screening during an annual wellness visit. Screening for
cognitive impairment, dementia, and Alzheimer’s has become paramount due to the
aging population o f America. Early recognition o f cognitive impairment through
screening can assist the NP in developing a eare plan to treat early symptoms and
possibly slow down or delay further decline. Drawing upon the concepts and constructs
of the HPM, the researchers will be able to use a more holistic approach in caring for
clients. Personal factors, such as age and self-motivation, help predict healthcare
behaviors and willingness to participate in a personal health promotion plan.
Recognizing perceived barriers such as fear o f losing independence is important when
promoting the early recognition o f cognitive decline. The HPM assumes that healthcare
professionals are part of the client’s interpersonal environment and can influence the
client throughout their life. Illuminating the need for cognitive impairment screening
each year during an annual wellness visit and applying education based on the HPM will
assist patients in overcoming perceived barriers related to a diagnosis o f cognitive
impairment and dementia.

Impact of the Problem
An extensive review o f literature was conducted to substantiate the necessity for
further research related to Mississippi’s PCPs regarding screening practices for cognitive
impairment. The review o f literature encompassed the effects o f various comorbidities,
consequences of use of certain pharmaceuticals, and the relationship o f laboratory studies
related to cognitive impairment. This literature review validated the need for more
extensive research.
The current researchers found studies that support the need for Vitamin B12,
Vitamin D, and GFR to be assessed during patients’ annual wellness visit. Patients with
diagnoses of depression and hypertension are more susceptible to develop cognitive
impairment or have a more rapid progression of the disease process.
According to Eastley, Wilcock, and Bucks (2000), it is standard practice to screen
for reversible causes o f dementia; however, it is unknown what the effects of vitamin
B12 deficiency actually are on cognition. Vitamin B12 deficiency makes up a very small
percentage o f reversible dementias. Previous studies have shown that B12 supplements
do not improve cognitive function or prevent cognitive decline. Therefore, according to
previous research, vitamin B12 deficiency does not cause or enhance dementia.
However, minimal research exist on the effects o f B12 on cognitive impairment or
cognitive decline.
The goal of this research was to determine if vitamin B12 supplementation can
improve cognition or if it can prevent cognitive decline in demented patients or in
patients with cognitive impairment. Eastley et al. (2000) attempted to prove that Vitamin
B12 treatment in non-demented patients will yield improvement of cognitive function.
No theoretical framework was identified for Eastley et al.’s (2000) study.

The sample consisted of 1,432 patients previously assessed at the Bristol Memory
Disorders Clinic between 1985 and 1998. The retrospective study divided patients into
two groups: (a) those with diagnosis of dementia and (b) those with no diagnosis but with
cognitive impairment. Numerous neuropsychological assessments were performed on the
sample, including the Mini-Mental State Examination, the Weehsler Adult Intelligence
Seale, and the Verbal Fluency Test. The patients who were treated with B12 replacement
therapy and who had a second assessment after treatment were matched for age and
diagnosis with patients whose B12 levels were within normal range upon the initial
examination. The differences in test scores pre-B12 therapy and post-B12 therapy were
compared to the test scores o f the first and second visits for the matched group. Data
between the two groups were compared using ehi-square and independent t tests (Eastley
et al., 2000).
Upon first assessment o f the patients {N= 1,432), 125 patients had B12 values
that were below the normal range. At the follow-up appointment 7-10 months later, 6
patients refused follow-up appointments, 9 patients did not return for follow-up, and 4
patients had their appointments cancelled by their residential homes. In addition, 3
patients were followed up by another facility, and 2 patients died before their follow-up
appointments. Therefore, 101 patients were seen for follow-up assessment. However, of
these, 4 did not receive B12 therapy because the level was just below normal and then
normal upon return, and charting was not available on 9 other patients (Eastley et al.,
2000).
O f the patients classified as dementia patients treated with B12 supplementation,
none o f them improved in all areas of cognitive testing. However, the patients did
improve minimally in memory testing and verbal fluency. The patients that were

matched who were not treated with B 12 therapy deteriorated slightly—but not enough for
statistical significance.
In the patients who had no dementia diagnosis but were cognitively impaired, the
results were different (Eastley et al., 2000). The group who were treated with vitamin
B12 had a statistical significance of improvement on the verbal fluency section of the
assessment, while the matched group deteriorated. Further, before the B12 therapy, the
scores for the verbal fluency test scores on the patients to be treated were much lower
than the matched group upon the initial assessment. In addition, 2 patients had
improvement on all areas of the testing after the B12 therapy. Therefore, in patients with
minimal cognitive impairment, cognitive function may be improved with vitamin B 12
therapy. However, in patients with dementia, there does not seem to be a benefit of
vitamin B12 replacement.
Eastley et al. (2000) stated that further investigation is needed on vitamin B12
deficiency in regard to cognitive decline. According to Eastley et al. (2000), more
research is needed to confirm the fact that B 12 therapy may improve cognitive
impairment, especially in the frontal lobe and language function. Eastley et al. suggested
that a larger prospective study be conducted to determine if the results are able to be
reproduced.
There were numerous problems of missing data throughout the research by
Eastley et al. (2000). This is partly due to the fact that this was a retrospective study, and
data were either lost or never charted. For some o f the testing, portions o f the results
were not available. It is unknown whether portions o f the testing were refused by
patients, were never given due to severity of cognition, or because of physical disability.
In addition, because of the elderly population, medication changes, deaths, or

institutionalization also eliminated portions of the data. Therefore, what seemed to be an
initially large sample size was decreased drastically (Eastley et al., 2000).
These data apply to the current researchers’ study which focused on identifying
cognitive impairment early and treating any deficiencies. If cognitive impairment can be
determined early and a patient is vitamin B12 deficient, then it is possible that
supplementation of vitamin B12 could help to improve frontal lobe and language
functioning on cognitive screening assessments. This research shows that nurse
practitioners need to be drawing lab work and attempting to treat any deficits in order to
catch cognitive impairment early and work on slowing its progression. The current
researchers were able to add B12 deficiency to the tool for the research project in order to
detect cognitive decline based on B12 deficiency.
Littlejohns et al. (2014) used a quantitative design to determine if low vitamin D
concentrations are associated with increased risk for all-cause dementia and Alzheimer
disease. This is concerning due to the high rates o f vitamin D deficiency in older adults
and the unknown causes o f cognitive impairment. No theoretical framework was
identified in the study (Littlejohns et al., 2014).
The hypothesis o f the study was to determine if vitamin D is neuroprotective.
The enzyme that synthesizes the biological effect o f vitamin D and the vitamin D
receptor are both found in the brain. Studies have been shown via in vitro that vitamin D
helps increase clearance o f amyloid plaques by increasing action o f macrophages.
Amyloid plaques are formed along with neurofibrillary tangles. These plaques and
tangles cause damage that is associated with Alzheimer’s disease.
Elderly ambulatory participants free from dementia, cardiovascular disease, and
stroke were seleeted from the Cardiovascular Health Study held between 1992-1993 and

1999 with a sample size of 1,658. Serum samples were collected in 1992-1993 for
determination o f serum 25-hydroxyvitamin D (25(OH)D) concentrations with the use of
liquid chromatography-tandem mass spectrometry. Verification by SRM 972 from the
National Institute o f Standards and Technology was used to test the calibration o f the
serum 25(OH)D. In 1998-1999, a group of appointed neurologists and psychiatrists
assessed the participants on the basis annual cognitive assessments by utilizing repeat
MRI scans, medical records, questionnaires, and proxy interviews. According to the
criteria o f National Institute o f Neurological and Communicative Diseases and
Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDSADRDA), incident all-cause dementia and Alzheimer’s disease were diagnosed
(Littlejohns et al., 2014).
After collection and analysis o f the data, the results confirmed that vitamin D
deficiency is associated with an increased risk o f all-cause dementia and Alzheimer’s
disease. Participants who were vitamin D deficient (> 25 nmol/L to < 50 nmol/L) or
severely deficient (< 25 nmol/L) were at a higher risk for development for both all-cause
dementia and Alzheimer’s disease. There was about a 51% increased risk for the
participants that were deficient; however, there was a 122% increased risk for the
severely deficient individuals. In this study (Littlejohns et al., 2014), there were few
cases o f vascular dementia due to the exclusion of cardiovascular disease and stroke
patients.
The biggest strength o f this research by Littlejohns et al. (2014) was the diverse
population size and included white and African-American men and women. Secondly,
the researchers also used an immensely thorough methodology approach. On the other
hand, the biggest weakness was that not all types of dementia were studied. Littlejohns et

al. (2014) stated that there was the need for conduction of further research consisting of
CVD and stroke patients; stroke risks are also associated with low vitamin D levels.
There were very few cases o f incident vascular dementia due to the exclusion of CVD
and stroke patients.
In conclusion, the results of Littlejohns et al. (2014) established that vitamin D
deficiency and the increased risk for all-cause dementia and Alzheimer disease are
associated. Multiple processes linking subnormal vitamin D levels and risk for dementia
were established. Areas that involved memory, such as the hippocampus and dentate
gyrus, included vitamin D receptors. Also, the enzyme that synthesizes the active form
of vitamin D is made in many regions of the brain; Vitamin D ’s active form regulates
neurotrophin expression and the survival, development, and function o f the neural cells.
This research by Littlejohns et al. (2014) was very useful to the students’ current research
as it identified the need for the assessment of patients with vitamin D deficiency to be
screened for cognitive impairments in primary and or acute care clinics. Littlejohns et al.
(2014) correlated to the students’ research question and helped in expanding the
knowledge needed in determining screening patients for cognitive impairment by
screening patients for Vitamin D.
Darsie et al. (2014) conducted a study to evaluate the association of kidney
function and cognitive impairment. Recent evidence has proven that decreased kidney
function is associated with cognitive impairment and declines in cognitive impairment.
Previous studies used creatinine as a means for measuring kidney function. Darsie et al.
felt that this was not the best way to evaluate kidney function due to the effects that aging
and decreased muscle mass had on creatinine. Darsie et al. found that Cystatin C was the
best way to evaluate kidney function because these levels are not affected by muscle

mass changes of the elderly. Therefore, Darsie et al (2014) considered it reasonable to
evaluate Cystatin C levels and performance of cognition using the Modified Mini-Mental
State Examination (3MS) to determine the effects kidney function had on cognition.
There was no mention of a basis for theoretical framework in this study (Darsie et al.,
2014).
Recent findings suggested that poor kidney function and cognitive impairment
were associated, and they were linked to an increased risk o f death. Due to the past
findings, Darsie et al. (2014) sought to further evaluate the link between poor kidney
function and cognitive impairment and their influence on death. During this study,
Darsie et al. hypothesized that “baseline cystatin C-based kidney function would be
associated with a decline in cognitive function and cognitive impairment free life years
(CIFLYs) and that these associations would be mediated by clinical cardiovascular
disease” (p. 69).
Darsie et al. (2014) examined the relation o f kidney function and cognitive
impairment o f 3,907 participants in four U.S. communities in California, Maryland,
North Carolina, and Pennsylvania. Participants meeting criteria of being 65 years old or
older, not institutionalized, remaining in the community for 3 years or longer, and not
receiving treatment for cancer were examined in the study. The participants were
evaluated annually during in-person visits from 1992 to 1999 using interviews and
physical examination. Blood specimens were drawn to evaluate serum cystatin C to
estimate yearly glomerular filtration rates (GFR), and the 3MS was administered to
monitor cognitive function. “Age, sex, race, smoking status, and educational level were
determined by self-reports at baseline. Hypertension was assessed at baseline using self-

reports and prescription medication. Blood pressure and diabetes were assessed annually”
(Darsie et al., 2014, p. 70).
Darsie et al. found that 20% o f those studied had a GFR of < 60, 62% had a GFR
o f 60-89.9, and 18% had a GFR o f 90 or higher. Participants with a higher GFR generally
were younger, female, s e lf reported nonwhite race, had a higher level of education, never
smoked, had a lower body mass index, and were less likely to have hypertension. Those
with a higher GFR also had higher scores on the 3MS. The study showed that
participants with a GFR of < 60 and those between 60-89.9 had faster declines in the
3MS compared to those with higher GFRs. Those with a GFR of < 60 proved to have a
lower average o f life-years compared to those with a GFR of 90 and above. They also
had fewer CIFLYs than those with a higher GFR. To validate Darsie et al.’s reasoning of
using cystatin C instead o f creatinine to evaluate GFR, they found that GFR based on
creatinine failed to find a significant difference in the decrease in 3MS per year. In
Darsie et al.’s study of the community dwelling elderly, they found that kidney function
elevated by cystatin C was associated with the level and change in cognitive function
over the 6 years o f study. Also noted throughout the study was the fact that those with a
decreased baseline GFR had a greater decline in predicted cognitive function. “Reduced
kidney function was also associated with fewer CIFLYs” (Darsie et al., 2014, p. 73).
One strong suit o f Darsie et al. (2014) was the study was conducted over a period
o f about 7 years. This period o f time afforded ample time to draw conclusions and facts
and ascertain if what they hypothesized would prove to be correct. Darsie et al. also used
a very large population size which enabled results to be generalized. Darsie et al.
indicated a limitation o f their study was the limited length o f follow-up. The study was
based off annual visits which did not include follow-up information.

Darsie et al. (2014) was useful in the student researchers’ study for validation o f
evaluating patients GFR, especially those estimated by cystatin C, and the relation to
those with cognitive impairment. In gathering this information from Darsie et al. (2014),
the student researchers were able to determine if the results could be replicated as they
were evaluating those 65 and older as well. The student researchers evaluated whether
cognitive impairment screenings are being done and what chronic diseases those with
cognitive impairment have, such as decreased kidney function.
Review of literature has been completed to support the need of assessing hearing
impairment and smoking status. Hearing loss and cognitive decline show a strong
correlation and needs attention in assessing risks for cognitive impairment. Smoking is
linked to cognitive impairment in later stages o f life.
Deal et al. (2015) compared hearing loss, hypertension, and the use o f hearing
aids with cognitive decline. The background and significance o f the study revealed that
hearing impairment is prevalent, modifiable, and has been associated with cognitive
decline. No theoretical framework was identified in Deal et al. (2015).
Data were obtained from a pilot study carried out in a subset o f participants from
the Atherosclerosis Risk in Communities Study (ARIC) to test the hypothesis that,
compared with participants without hearing impairment (HI), participants with HI in
older age have poorer cognitive performance, measured by multiple cognitive tests, both
cross-sectionally at the time when hearing is measured and longitudinally, when a faster
rate of 20-year change in cognitive functioned measured from midlife to older age. They
hypothesized that, among participants with HI, those with hearing aids have slower rates
o f cognitive decline than those with HI who do not use hearing aids (Deal et al., 2015).

The ARIC study is a population-based prospective cohort study of 15,792 men
and women between 45 and 64 years o f age recruited in 1987-1989 from 4 U.S.
communities (Washington County, MD; Forsyth County, NC; Jackson, MS; and
Minneapolis, MN). The participants returned for a 5th ARIC visit in 2011-2013. A pilot
study on hearing was initiated at the Washington County site in 2013, and audiometric
testing was offered to 307 participants at their checkup. Six declined participation, and
46 did not complete the examination (45 because of impacted cerumen in one or both
ears). Since only 2 participants were nonwhite, analysis was restricted to self-reported
whites, resulting in an analytical sample o f 253. Participants were older with an average
age of 77.1 years and more likely to have a high school education or less. Following
informed consent, a comprehensive neuropsychological battery was administered. The
following domains were included: (a) Memory-Delayed Word Recall Test (DWRT) (7),
Incidental Learning Test (8), and Logical Memory Test I and II (9); (b) Language-Word
Fluency Test (10), Animals Naming Test (11), and Boston Naming Test (12); and (c)
Processing speed/attention-Digit Symbol Substitution Test (DSST) (13), Digit Span
Backwards Test (13), and Trail Making Test Parts A and B (14-15) (Deal et al., 2015).
Pure tone air conduction audiometry was conducted in a sound-treated booth in
2013. Thresholds in each ear were obtained by standard octaves from 0.5 kHz to 8 kHz
by trained technicians using insert earphones. Hearing impairment was as follows:
normal < 25dB, mild 26-40 dB, and moderate/severe > 40dB). Only 5 participants had
severe HI. Hearing aid use was self-reported.
Demographic information was collected in 1987-1989, including age (years), sex,
and education (< 12 years and >12 years). Smoking was recorded as ever or never.
Hypertension (19) was considered present if diastolic > 90mm Hg, systolic ^ 140mm Hg,

or if medication was taken for hypertension. Diabetes (19) was defined as BG >126
fasting, > 200 nonfasting, or medication taken or medical diagnosis recorded. Depressive
symptoms were measured in 1990-1992 using 7 items that relate to depression from the
21 -item Maastricht Questionnaire, which assesses vital exhaustion. Items were scored as
0 = No, I = Don't know, and 2 ^ Yes and summed to yield a possible score ranging from
0 to 14, with higher scores indicating depressive symptoms.
O f 253 participants, 73 (29%) had no HI, 95 (37%) had mild HI, and 85 (34%)
had a moderate or severe HI. Mean age at the time o f the assessment was 76.9 years, and
58.9% o f participants have a high school education or less. On average, participants with
moderate/severe HI were older (79.4 years) and more likely to be male (54%) and have
hypertension at baseline (33%) than participants with mild or no HI. Mean test scores for
memory, language and processing speed/executive function were poorest for participants
with moderate/severe HI and best for participants with no HI. Among the 85 participants
with moderate/severe HI, 51% reported using a hearing aid. Compared with hearing aid
users, nonusers were more likely to have hypertension and diabetes.
The results demonstrate that moderate/severe HI measured in late life was
associated with poorer concurrent memory performance and with a faster rate of prior 20year decline in both memory and global cognitive function. HI has also been
hypothesized to be a causal risk factor for cognitive decline, increased social isolation
and loneliness, increased cognitive load, and changes in brain structure. Social isolation
is associated with physiological changes, such as increases in systolic blood pressure and
increased glueocorticosteroid levels, which could in turn impact brain structure and
cognitive decline (Deal et al., 2015).

Limited study participants consisted of only whites from Washington County,
MD (Deal et ah, 2015). Additionally, there were no data on duration of HI.
There is a strong correlation between hypertension, DM, hearing loss, and
cognitive decline. Deal et al. (2015) was a good foundation for the student researchers in
comparing patients with hearing impairment and correcting that to cognitive decline.
Rusanen, Kivipelto, Quesenberry, Zhou, and Whitmer (2011) attempted to
determine if there is any relation to smoking, particularly during mid-life, and the risk of
dementia, including AD and vascular dementia (VaD). It is well-known that smoking
causes cancer, increases risk for cardiovascular illnesses, increases respiratory distress,
and increases risk for stroke. However, when smoking has been studied in relation to
Alzheimer’s disease and dementia, there are conflicting results. While the few studies
conducted are controversial, some studies show that smoking can even reduce the risk of
cognitive impairment. No theoretical framework was used as a basis for this
investigation.
Rusanen et al. (2011) expected to find results similar to the results of dementia
findings in previous studies and see dementia in older people with fewer years of
education. In addition, Rusanen et al. expected to find that women have a higher
percentage o f dementia. According to previous studies, the incidence o f smoking and
dementia is greater in African Americans than in the white or Asian populations.
Rusanen et al. (2011) expected to see this trend as well as a predisposition to VaD due to
smoking with increased risk for stroke associated with smoking.
The sample consisted of every participant between 50 and 60 years o f age who
completed a Multiphasic Health Checkup in San Francisco and Oakland, CA, between
1978 and 1985. The Multiphasic Health Checkup was completed by patients who

participated in a voluntary health examination at a Kaiser Permanente facility in northern
California. When electronic dementia diagnosis was available in 1994, the records were
pulled of those patients who were still alive and still members o f the health plan, which
included 21,123 people o f varying race, age, and sex. If the smoking status was not
included in the initial exam, the participants were excluded (Rusanen et al., 2011).
On the initial Multiphasic Health Checkup, the patients were asked numerous
questions regarding their health status and family history. They were asked their
smoking status o f never, former, or current smokers, and current smokers were asked to
quantify their smoking habits. The current smokers were divided into < 0.5 packs per
day, 0.5-1 packs per day, 1-2 packs per day, and > 2 paeks per day. Comorbidities, such
as diabetes, hypertension, hypercholesterolemia, cardiovascular disease, and strokes,
were recorded from the beginning of data collection to the end of data collection.
The diagnosis of dementia was obtained through medical records from 1994-2008
as either AD, VaD, or unspecified dementia diagnosed by a neurologist or a
neuropsychologist. SAS 9.1 was used to perform all statistical analyses.
Sociodemographic and clinical characteristics were compared using the chi-squared test.
The Cox proportional hazards model was used to determine if there was relationship
between midlife smoking and diagnosis o f dementia, AD, or VaD. Incidence rates were
determined by age categories o f younger than 77, 77-81, 81-85, and older than 85 years
(Rusanen et al., 2011).
After a mean follow-up of 23 years, 5,367 people were diagnosed as having
dementia. More women than men were diagnosed. Participants were also older with
fewer years o f education, and more African Americans had the diagnosis as well. There
was a higher percentage o f divorced, widowed, or separated people with dementia than

those who were married, and a higher percentage of people who had never drank alcohol
were diagnosed. A higher BMI in midlife and numerous comorbidities were also found
in those diagnosed with dementia.
As for smoking, there was a drastic increase in dementia, AD, and VaD noted for
the individuals who smoked > 2 packs a day during midlife compared to nonsmokers.
The increase in risk was less significant in the other smoking categories, and negligible in
the former smokers or < 0.5 packs per day. Stroke was found to be highly associated
with smoking and the risk for dementia. The risks for dementia, AD, and VaD were
found to increase as the amount o f cigarettes smoked on a daily basis during midlife
increased. This research study by Rusanen et al. (2011) is important in an attempt to
identify risk factors for dementia, AD, and VaD and help to prevent the occurrence later
in life.
Rusanen et al. (2011) indicated a need for further research to determine the
cerebrovascular and neuropathologic changes that smoking causes in the brain which lead
to dementia. Rusanen et al. encouraged further investigation to indicate smoking as a risk
factor instead o f a risk predictor for dementia.
The major strength of Rusanen et al. (2011) was the longitudinal aspect. The
same patients were able to be studied 20-30 years after initial health examinations.
Therefore, their entire health history had been recorded prior to any diagnosis of
dementia or any outward signs o f dementia which strengthens the end results and leads to
internal validity.
One weakness noted in Rusanen et al. (2011) was the way the age brackets of
diagnosis were broken down. When there are categories that overlap, it is impossible to
know in which category each result will be placed. For example, the age groups were <

77 years old, between 77-81 years old, 81-85 years old, and then > 85 years old. There
was no way to know where the 81 -year-olds were placed because they overlapped into
two categories. In addition, the category age was > 85 years old, but it should have been
86 years old and above, so as not to be confused where to put the 85-year-olds. Another
weakness that the researchers stated was the diagnosis of dementia. Some patients were
diagnosed as AD, some as VaD, and some with no specification. All patients were
diagnosed by neurologists or neuropsychologists, but the difference in diagnosis
techniques and how they were diagnosed were unknown.
The current student researchers focused on early detection o f cognitive
impairment and the implications o f screening practices by practitioners. Since this
research indicated that the more a person smokes in midlife, the higher the correlation of
dementia diagnosis later in life, it was important for the student researchers to also
investigate whether practitioners are obtaining a smoking history and educating on the
evidence-based findings o f the potential o f AD and VaD later in life. This smoking
history, in addition to yearly cognitive screenings, could help diagnose early dementia,
which can be treated to slow the progression o f the disease in patients.
Goldstein, Levey and Steenland (2013) used a prospective longitudinal cohort
design to identify if high blood pressure levels are associated with a more rapid decline in
particular cognitive domains. No theoretical framework was identified for this study.
Detection o f a correlation between hypertension and progression of cognitive decline is
crucial for advancement in primary care prevention o f cognitive impairment. It is
projected by the year 2050 that 15 to 18 million people 60 years old and over age group
will develop dementia, 70% o f these individuals will also have a diagnosis o f
hypertension. Various studies have been conducted in the past that have raised

controversy on the link between cognitive impairment and hypertension, and some of the
studies found an association while others failed to find a correlation. The National
Institutes o f Health (NIH) found that many of these studies were inadequate due to the
procedures utilized for defining cognitive impairment and the methods employed for
diagnoses of hypertension. Despite the errors in some previous studies, Goldstein et al.
(2013) noted that there was a great deal of encouraging findings related to employing
lifestyle changes in prehypertensive and hypertensive adults to decrease their blood
pressure which in turn resulted in improved psychomotor speed, memory, and executive
function.
Goldstein et al. (2013) comprised a study to determine if there was an association
between elevated blood pressure and decline in individuals with cognitive impairment
over a 2-year period. It was hypothesized that the participants diagnosed with mild
cognitive impairment who presented with high blood pressure readings according to
hypertensive guidelines on more than one occasion over the two-year period would suffer
a more rapid overall cognitive decline than those with normotensive levels. Goldstein et
al. sought to develop a study that would delineate with greater exactitude the
interconnection o f hypertension and cognitive decline. The participants in the study had
a definite diagnosis o f mild cognitive impairment and the comorbidity o f hypertension.
To achieve a more reputable and reliable study, participants underwent multiple
neuropsyehological tests as opposed to a single measure. To better diagnose true
hypertension, the blood pressure levels o f participants were examined at annual follow-up
visits instead o f reliance on a single baseline visit.
Participants (N = 1,385) in Goldstein et al.’s (2013) study were diagnosed with
mild cognitive impairment. Information for the study was collected as part o f the

Uniform Dataset, a data protocol maintained by the National Alzheimer’s Coordinating
Center. Participating organizations included 31 National Institute on Aging Alzheimer’s
Disease Centers nationwide. The recruitment strategies utilized by the Alzheimer’s
Disease Center’s varied participants could come from the clinics themselves or be
members of the local community. Inclusion criteria remained the same for all
participants. Each participant had to be diagnosed with mild cognitive impairment by a
clinician at the center and have no recent history or diagnosis of stroke or transient
ischemic attack (TIA). To assess the current overall functional status and cognitive
function o f participants, the Clinical Dementia Rating Sum was conducted on each
participant. Baseline blood pressure readings and readings for at least two subsequent
follow-ups were also required of participants. The participants were monitored over the
course of 3 yearly visits. At each visit, systolic and diastolic blood pressures were
obtained with the participant in a seated position, and neuropsychological testing was
conducted to assess for any changes in cognitive function.
To establish whether there was a difference in cognitive funetion over time
between those with high and normotensive blood pressure readings, researchers
conducted a longitudinal linear regression analyses. O f the 1,385 participants, 15% had
high blood pressure readings on all three occasions, and 23% had high readings on two
the three occasions, 27% had one high reading, and 35% had no high readings. When
neuropsychological test results were evaluated, the performance o f participants with high
readings on two to three occasions significantly declined on visuomotor sequencing, set
shifting, and naming. There were no significant negative outcomes detected in the
participants that had normotensive blood pressure or those with one occasion of

high blood pressure. The implications o f these research outcomes support association
between high blood pressure and risk o f cognitive decline in those with cognitive
impairment (Goldstein et al., 2013).
The biggest strength related to Goldstein et al.’s (2013) study was that the study
addressed and corrected methodological problems mentioned in recent reviews related to
this type of study. The researchers achieved this by not relying on self-reported
diagnoses o f hypertension by participants that can often be inaccurate, as the participants
may have never been truly diagnosed with hypertension by a healthcare provider.
Instead, Goldstein et al. (2013) referenced actual systolic and diastolic readings.
Goldstein et al. further solidified their research by not basing their statistics on a single
reading at one point in time. On the other hand, weaknesses can be found within this
study including duration of follow-up period and reliance on an established database. A
longer duration of study would allow researchers to identify if the relationship between
hypertension and cognitive decline persisted over time. Extended duration of study
would also allow researchers to study how profound the effect o f uncontrolled blood
pressure is on cognitive impairment over the course o f a greater part of the participant’s
lifespan. The reliance on an established database limited this study as well. The
researchers recognized this weakness and stated that there were possibly many
mechanisms through which elevated blood pressure could affect cognitive decline.
Goldstein et al. (2013) recommended further research where these associations could be
better studied with a mediation model or a longitudinal study.
Richard et al. (2012) used a cohort study o f a multiethnic community to evaluate
the association o f late-life depression with mild cognitive impairment and dementia.
There was no theoretical framework identified in this study. Depression and the

progression or increased risk o f cognitive impairment have been long reported in
prospective studies conducted in a memory clinic setting, but no association has been
found in population-based studies.
Richard et al. (2012) noted that inconsistencies existed in previous studies that
attempted to correlate late-life depression with incident dementia and the studies that
sought to evaluate depression and mild cognitive impairment. With the undertaking of
this new cohort study, Richard et al. sought to resolve and clarify a number o f the
inconsistencies published in prior studies.
These researchers composed a study that consisted o f 2,183 participants. The
participants were composed o f healthy individuals over the age of 65 years who were
Medicare eligible. The participants resided in low-income neighborhoods situated in
northern Manhattan. The participants were selected by systematic random sampling
based on ethnicity and age group. Ethnicities included, Hispanic, non-Hispanic, blacks,
and whites. Age groups were classified as 65-74 years old and > 7 5 years old.
Participants were excluded from the study if they had been previously diagnosed with
dementia by a physician. A baseline visit was conducted where the participants were
evaluated using neuropsychological testing for dementia and screening for depression
using the short version o f the Center for Epidemiological Studies Depression scale. A
score on the scale > 4 indicated a diagnosis of depression in individuals. The
neurophysiological testing was then administered at subsequent follow-up visits at
intervals o f 18 and 24 months.
Richard et al. (2012) concluded that there is an association of depression with
prevalent mild cognitive impairment, but depression does not precede or cause cognitive
impairment in itself. In turn, the researchers did discover that there is a link that

correlates depression and the progression of mild cognitive impairment to dementia.
Richard et al. stated that at baseline there were 320 participants diagnosed with a form of
mild cognitive impairment, 160 with amnestic mild cognitive impairment, and 160 with
non-amnestic mild cognitive impairment. O f the 320 individuals, 67 progressed to
dementia. Richard et al. discovered that participants with a dual diagnosis o f depression
and mild cognitive impairment were at twice the risk to develop dementia when
compared to the participants with mild cognitive impairment that lacked depressive
symptoms.
Richard et al. (2012) did not directly speak to the need for future research in their
study but did recognize limitations that could be addressed in future research studies.
The limitations recognized by the researchers included that the Centers for
Epidemiological Studies Depression Seale only inquired about depressive symptoms
experienced within the last 2 weeks. Limiting the individual's experience o f depressive
symptoms to such a short span of time could overlook those who have experienced
depressive symptoms in the past but not within the given timeframe. Richard et al. also
stated that they did not explore all possible explanations for the relationship between late
life depression and dementia, such as the possibility that depression could affect the
threshold for dementia to become manifest. A weakness not addressed by the researchers
regarding their study was the selection o f participants. The study used participants from
a predominantly low-income neighborhood. The use o f participants with poor economic
status raises the question that their incidence of depression could be somehow linked to
their socioeconomic status and current living conditions. The study by Richard et al.
(2012) could be recreated in the future with a broader participant base and with
participants from multiple socioeconomic levels.

The greatest strength of Richard et al. (2012) was that the researchers assessed
depression and mild cognitive impairment over a span of 3 subsequent visits which
allowed time for change and progression to be analyzed. In addition, the inclusion of
multiple ethnicities was a strength of this study. The researchers included persons from a
variety o f ethnic backgrounds— allowing a wider range of analysis. Furthermore, the
exclusion of patients with prior physician diagnosis dementia added to the validity o f the
study (Richard et al., 2012).
In conclusion, Richard et al. (2012) was useful in the review o f literature for the
current student researchers’ study on primary care providers’ detection o f cognitive
impairment during the annual wellness visit. The research by Richard et al inferred that
depression does not precede cognitive impairment, yet it does accompany it and often
hastens the progression o f mild cognitive impairment to dementia. The student
researchers can use this information as part of the tool used in evaluation o f cognitive
impairment screening by providers. Having the research supporting this correlation
indicates the need for adequate and thorough evaluation o f patients with mild cognitive
impairment and accompanying comorbidities such as depression. Richard et al.’s (2012)
study revealed the need to promptly assess those positive for mild cognitive impairment
for any depressive symptoms to detour faster and further advancement of cognitive
impairment. Preventive strategies, such as medication management, teaching, and
counseling can be put in practice to slow the progression of decline and treat patients’
accompanying depression, thereby enabling the patient to live a more fulfilling and
happier life while maintaining their current state o f cognition for a longer period of time.
Certain medications need to be assessed along with polypharmacy to help primary
care providers assess for risks o f cognitive impairment. Other medications that need to

be analyzed is the use of anticholinergics as they are associated with increased risk for
dementia. Heavy use o f opioids have been examined to support the need for cognitive
impairment screening.
Gray et al. (2015) conducted a population-based longitudinal study of persons 65
years and older to examine the association between long-term cumulative anticholinergic
use and increased risk for dementia. Anticholinergics are used frequently by older adults
for the treatment of overactive bladder, seasonal allergies, depression, and COPD.
Significance of this study was to provide a possible association with the cumulative use
of anticholinergics in the elderly to increased risk for dementia, thus leading to increased
awareness among healthcare providers o f this potential association. No theoretical
framework was mentioned in this study.
Gray et al. hypothesized that higher cumulative use o f anticholinergics would be
associated with increased risks of dementia. Another hypothesis was that if an
association was based solely on treating prodromal symptoms, then the association would
be found for antidepressants but not for other anticholinergic classes.
The study was conducted on participants from the Adult Changes in Thought.
(ACT) study. The ACT is an ongoing longitudinal study of older adults in the Seattle area
that focused on ways to delay or prevent dementia. All members o f the ACT study were
members of Group Health (GH) whieh is an integrated healthcare delivery system. The
participants were 65 years or older and were randomly sampled from the GH members.
None of the participants had dementia upon entry, and all participants had been in the GH
health system for 10 years prior to beginning the study. At least one follow-up visit post
enrollment was required. O f the 4,724 participants in the ACT study, 3434 were eligible

for the present study. The analysis o f this study included participant data through
September 30, 2012.
The Cognitive Abilities Screening instrument was used to screen for dementia
upon entry into the study and at each biennial study visit. Scoring ranges were from 0100; the higher the score, the better the cognitive performance. T hose scoring 85 or less
were then evaluated for dementia using physical assessment and neurologic assessment.
Those that were diagnosed with new-onset dementia had at least one annual follow-up
examination to confirm the dementia diagnosis. Hazard ratios and 95% confidence
intervals for the association between anticholinergic use and dementia were estimated
using the multivariable Cox proportional hazards regression models.
Data (the drug name, strength, route of administration, date dispensed, and
amount dispensed) were collected from a computerized pharmacy dispensing system.
Examples o f medications commonly prescribed included chlorpheniramine, doxepin,
oxybutynin, meclizine, and olanzapine. A total medication dose was calculated for each
prescription filled, and then a standardized daily dose was calculated in order to create
exposure measures. Cumulative use was categorized ranging from no use to > 3 years.
The heaviest level of exposure was reached if participants took any o f the mentioned
medications for more than 3 years.
Gray et al. (2015) found that 78.3% of the participants had at least one refill for an
anticholinergic during the 10 years before study entry. More than 90% of the
anticholinergics used were antidepressants, antihistamines, and bladder antimuscarinics.
During follow-up of 7.3 years, 797 o f the 3,434 eligible participants (23.2%) developed
dementia. O f these, 637 (79%) developed Alzheimer’s disease. Those in the highest
exposure category with a standardized daily dose > 1,095 showed a notable increase in

the risk for dementia (adjusted HR, 1.54 [95% Cl, 1.21-1.96]) eompared to those with no
use o f anticholinergics. This analysis statistically supported the first hypothesis that
higher cumulative use of anticholinergics would be associated with increased risk of
dementia. The findings o f Gray et al. (2015) proposed that primary care providers need
to be aware of the possible association o f cumulative anticholinergic use and the
increased risk for developing dementia. Decreasing anticholinergic use is a potentially
modifiable risk factor to developing dementia.
Gray et al. (2015) identified several strengths o f the study. Using computerized
pharmacy data, they were able to describe medication use 10 years prior to enrollment.
The researchers were able to look at medications by drug class, which allowed
comparison o f effects between drug classes. The researchers excluded prescriptions that
were filled within the most recent 1-year period, thereby eliminating protopathic bias. A
large community-based sample and a mean follow-up of > 7 years were additional
strengths o f the study. Weaknesses included the fact that some first-generation
antihistamines are available as over-the-counter medications and may lead to
misclassification of exposure. Also, reliability was based on prescriptions filled but did
not guarantee that the medication was administered. Gray et al. (2015) suggested the
need for further studies to better understand whether dementia is gradually reversed after
discontinuing therapy.
The findings o f Gray et al. (2015) provide a strong basis for screening to detect
cognitive impairment during the Medicare annual wellness visit. This yearly “wellness”
visit was designed for the beneficiary of Medicare to develop or update a personalized
plan along with the primary care provider to assist in preventing disease and disability as
well as early detection o f changes in cognition. Identifying risk factors and conditions

that can benefit from evidenced-based interventions are included in the annual wellness
visit. Based on the findings o f this study, primary care providers need to be aware of the
risk for dementia with cumulative use of anticholinergics. Medication review and update
are included in each annual wellness visit as well as assessment for cognitive impairment
which can assist both provider and beneficiary to work together in creating a personalized
prevention plan and detection o f cognitive impairment or dementia.
Dublin et al. (2015) used a quantitative design to determine if prescription opioids
increased risk for dementia or cognitive decline which is concerning due to the high
percentage of prescription opioid use among the elderly population ages 65 years and
older. Delirium may be caused by opioid use which, in turn, may increase the risk for
dementia. Sedation is one cognitive side effect of opioids. Neuropathological changes
have been shown in young adult, drug abuser autopsies similar to those o f AD.
Microglia, the immune cells in the brain that mediate inflammation, are modulated by the
effects of opioids. These effects may lead to neurodegenerative changes that cause
cognitive impairment. Opioids also stimulate eell death of mieroglia and neurons. This
evidence supports the theory that long-term opioid use may contribute to decline in
cognition. No theoretical framework was used in this study.
The hypothesis of Dublin et al. (2015) was to determine if accumulative exposure
and more recent opioid use would be associated with higher risk o f impaired cognition.
The examination between prescription opioid use and risk of dementia or impaired
cognition was the goal o f this study.
Dublin et al.’s (2015) study consisted o f 3,434 participants, aged 65 years and
older, without dementia. The participants were selected from GH, an integrated
healthcare delivery system based out of Seattle, Washington. The participants were

enrolled with GH for a minimum of 10 years to ensure sufficient data on long-term
medications. The participants were selected between 1994 and 1996. From 2000
through 2003 and in 2004 an expansion cohort was also recruited. The Cognitive
Abilities Screening Instrument (CASI) was completed every 2 years and continued until
September 30, 2012. The CASI results ranged from 0-100. Individuals scoring 86 or
lower went through further evaluations by a study physician and neuropsychological
testing. If the patient was diagnosed with dementia, he or she would be reevaluated in
one year to confirm the diagnosis. The goal was to look for a more rapid cognitive
decline versus individuals that have not developed dementia or cognitive impairment.
Therefore, participants were excluded with a diagnosis o f dementia because it would
have skewed the results of this study. Computerized pharmacy information was used to
identify prescription opioid use, including drug name, strength, route of administration,
number o f pills, and date dispensed. The medications were converted to morphine
equivalent portions using factors o f conversion. Total standardized doses (TSDs) were
calculated from the morphine conversions forming the calculation that one TSD = 30mg
o f morphine. Nonsteroidal anti-inflammatory drugs (NSAIDs) are medications that may
be used for treatment o f pain and may be considered as therapeutic as opioids. NSAIDs
use was also evaluated in this study as a seeondary analysis. NSAIDs were categorized
as 0 to 60, 61 to 180, 181 to 540, or 541 or more TDSs. The heaviest exposure of
ibuprofen was by using 1,200 mg daily for about 1.5 years.
The results of Dublin et al. (2015) suggested the participants with the heaviest
opioid (>91 TSDs in the past 10 years) or NSAID (> 541 TSDs) use had slightly higher
dementia risk than participants with little or no use. However, a more rapid cognitive
decline with opioid use was not associated. Moderate use of opioids and NSAIDs were

not associated with dementia risks. The participants with the heaviest use o f opioids
were a little older and mostly female. They were also more likely to have an increase in
comorbidities (e.g., obesity, self-rated health as poor or fair, and depressive symptoms)
and were unlikely to participate in exercise than individuals with little or no use of
opioids.
Strengths o f Dublin et al. (2015) were the large population size and detailed
pharmacy database. The study of long-term medications provided sufficient material to
Dublin et al. (2015). However, due to the fact that NSAIDS are over-the-counter, selfreporting o f medications must have been assessed periodically. The small increase in risk
for cognitive impairment of heavy use of opioids needs further attention. Heavy
accumulative use o f opioids may truly increase the risk for dementia. The fact that the
need for heavier use of opioids may be due to the state of poorer health compared to the
participants with little or no use. Other cofactors may not have been examined and
accounted for in the study. Other studies have suggested that structural brain changes
may be due to chronic pain, including a global decrease in gray matter volume and
density, particularly in the areas o f the brain that are related to pain processing.
In conclusion, the results of Dublin et al.’s (2015) study established that the
heaviest use of opioids had a slight increase in risk for dementia. This is useful in the
student researchers’ study because it helps identify the need for primary care providers to
assess for opioid use in conjunction with polypharmacy. Evaluating polypharmacy is an
intervention needed to help eliminate risk factors for cognitive impairment.
The tools used to assess cognitive function need to be analyzed if primary care
providers are performing the screenings. The following study by De Gobbi Porto et al.
supports the need for assessment so patients can be treated to slow progression of the

disease. De Gobbi Porto et al. support the fact that most patients do want to have their
Medicare annual screening performed.
De Gobbi Porto et al. (2013) used a quantitative design to evaluate the diagnostic
accuracy of cognitive screening tests to differentiate mild cognitive impairment from
subjective memory complaints. De Gobbi Porto et al. developed a scoring system
derived from the tests to aid in improving the ability o f healthcare providers to
differentiate between the two conditions. No theoretical framework was identified for
this study. Complaints related to memory problems are a frequent occurrence in primary
care, and providers often find it difficult to differentiate between patients with mild
cognitive impairment and those that are subjective memory complainers. Patients with
mild cognitive impairment present with subjective complaints of cognitive decline that
are accompanied by objective decline in neuropsychological evaluation, yet due to their
preservation o f functionality they do not yet meet the criteria for diagnosis o f dementia.
Mild cognitive impairment may be due to degenerative diseases or psychiatric disorders.
It can also represent the transitional state between cognition o f normal aging and the
development o f dementia. In contrast, subjective memory complainers present in clinics
with subjective complaints of cognitive decline as well but do not display decline upon
neuropsychological evaluation. Multiple interventions have been identified that
significantly slow the progression o f mild cognitive impairment to dementia, which
makes early diagnosis paramount. Cognitive screening tools are essential in the
differentiation between mild cognitive impairment and subjective memory complaints;
therefore, diagnostic accuracy and scoring related to these tests are imperative to proper
diagnosis.

De Gobbi Porto et al. (2013) identified methods of neuropsychological testing
used in primary care, the Mini-Mental State Examination (MMSE) and the Brief
Cognitive Battery Examination (BCB). The researchers then added delayed recalls in the
MMSE and a phonemic fluency test o f letter P fluency (EPF). A score was then created
for these tests that they hypothesized would be capable o f discriminating between mild
cognitive impairment and subjective memory complaints.
This study by De Gobbi Porto et al. (2013) was conducted on volunteers from the
local community over the age o f 60 years who spontaneously expressed complaints of
cognitive decline upon completion o f a memory complaint questionnaire. For
preliminary evaluation, the participants were submitted to clinical evaluation using the
MMSE, BCB, EPF, and delayed recall. Participants were then screened with the
Geriatric Depression Scale (GDS), Geriatric Anxiety Scale (GAS), and the Functional
Activities Questionnaire (FAQ). The researchers then used these scores to exclude
patients who scored > 4 on the FAQ and > 5 on the GDS. Participants believed to have
dementia, those with active neuropsychiatrie conditions, those with conditions that could
have affected their cognitive performance, and participants with < 8 years of formal
education were excluded from the next round o f neuropsychological testing. The
remaining eligible participants were tested further with vision and verbal tests
administered by an experienced neuropsychologist.
After collection and statistical analysis of data, the results revealed that, out o f a
total of 106 participants, 32 were found to be subjective memory complainers, and 74
were found to have mild cognitive impairment. The results established that a score
acquired from screening tests can distinguish with moderate to good accuracy between
mild cognitive impairment and subjective memory complainers. The MMSE, LDR,

delayed recall o f BCB, and LPF showed a statistically significant difference between the
two groups. The researchers then calculated the highest average o f the sum between
sensitivity and specificity to determine the best cut-off score for each test and added
together final scores o f all tests creating an overall final score. The implications of the
research outcomes in this study are very important to advancing development in testing
for cognitive impairment in primary care.
The biggest strength related to this study was the selection o f screening tests used
to evaluate the participants. The screening tests utilized can be conducted easily with
minimum training or supplies in a timeframe o f < 15 minutes, which is ideal for the often
fast-paced setting of primary care. On the other hand, several weaknesses can be found
within this study, including population, sample size, and selection o f participants. With
such a small sample size totaling 106 participants, it is unclear if this is an adequate
representation o f the population. The criteria that had to be met by participants including
lack o f certain disease processes and education level greatly limited the study as well—
excluding a vast number o f individuals such as those suffering with depression and those
who only obtained low levels o f education. De Gobbi Porto et al. (2013) acknowledged
these weaknesses and recommended that further study be conducted in a different
population with a larger number o f subjects and varied education levels.
In conclusion. De Gobbi Porto et al. (2013) was useful in the review of literature
for the current student researchers on cognitive impairment. The current research and
methodology varied, yet the assessment o f primary care providers and their use of
appropriate screening tools for the early detection of cognitive impairment were the
central focus in the research as well. This study also emphasized the direct association
between early detection o f true cognitive impairment and prompt implementation of

preventive strategies to help slow the disease process of dementia. Results obtained from
this study and the researchers’ own suggestions for further studies in different and larger
populations validate that there is need for more in-depth and continued research related to
the detection of cognitive impairment in primary care.
Eichler et al. (2015) performed a quantitative study that sought to address the
effect o f screening for cognitive impairment in primary care practices and the subsequent
formal diagnosis rate o f dementia. The significance of this study was to show that a
considerable amount o f patients may go undiagnosed without the use of cognitive testing
tools and that recognizing cognitive impairment in older patients due to screening could
result in a proactive stance in initiating adequate treatments earlier in the disease process.
No theoretical framework was identified within this study.
No hypotheses were clearly stated in Eichler et al. (2015), but several statements
throughout the study pointed to the apparent questions the researchers were attempting to
answer. Eichler,et al. mentioned implementation of the annual wellness visit for
Medicare used in the United States that includes assessing for any cognitive change and
also the proactive dementia case finding scheme in the United Kingdom which was
implemented with the aim o f improving the diagnosis rate o f dementia, thus improving
the care o f these patients. With no recent data on screening for dementia in Germany,
Eichler et al. sought to contribute empirical findings to the effect o f a screening test for
dementia in German primary care clinics on the rate o f formal diagnoses. The
researchers also aimed to contribute findings to the distribution o f etiologies of newly
assigned diagnoses as well as factors that could be associated with positive dementia
screening and formal diagnosis of dementia.

A cross-sectional analysis was performed on data gathered from the ongoing GPbased, randomized, controlled intervention trial. The trial is known as the DelpHI-MV.
This trial, which consist of an intervention and control group, was designed to test the
efficacy and efficiency o f implementing a subsidiary support system for persons with
dementia who live at home. Eligibility for the study was based on age > 7 0 years old and
living at home. Eligible patients were then screened at GP-practices using DemTect,
which is a personal interview-based tool that includes five tasks: (a) recall of a word list,
(b) number transcoding task, (c) work fluency task, (d) digit span reverse, and (e) a
delayed recall o f word list. The DemTect helps in deciding whether cognitive
performance is adequate for age (13-18 points) or whether MCI (9-12 points) or dementia
(8 points or below) should be suspected. A DemTect score o f < 9 was part of the
inclusion criteria. The patients that met these criteria were informed about the study by
their GP and were invited to participate. Upon agreeing to participate, they were required
to provide written informed consent. An ethics committee approved the informed
consent. Study enrollment began January 1,2012. The participants were then assigned
to an intervention or control group which was dependent upon randomization to an
intervention or control group o f the GP-practice. The intervention group received the
DelpHI-intervention, the independent variable; and the control group received care as
usual. O f the 4,064 patients that were screened at 108 participating GP-practices, 692
patients were eligible for the DelpHi trial. O f these, 406 agreed to participate in the
study. Another 163 patients were then excluded for various reasons, such as not starting
the baseline assessment, death, or relocation. Preliminary data, which included the
completed baseline assessment regarding relevant variables, were available on January 1,
2014, for the 243 patients that remained. From this group, 97 (40%) had already been

diagnosed with dementia before the screening. Analysis of the study was based on data
from 146 patients that had not received a formal diagnosis of dementia before screening.
The German version o f the MMSE for cognitive status, the Geriatric Depression Scale,
and the Bayer Activities of Daily Living Scale were the instruments used along with
demographic data, including age, sex, and living situation to describe the sample.
Descriptive statistics were used to summarize the socioeconomic and clinical
characteristics o f the study sample. Patients were categorized into two groups: patients
that were diagnosed with dementia after screening and patients that were not diagnosed
with dementia after screening. O f the 146 patient sample, 74 were not formally
diagnosed and 72 were formally diagnosed with dementia. The analysis suggested favor
of screening for dementia. The overall diagnosis rate of dementia increased from 40%
before screening to 70% after screening. The study analysis revealed that 74% o f those
that were formally diagnosed were women. The statistics further illustrated that
cognitive impairment scores from the MMSE were lower for women when compared to
the total sample score. This factor should be implicated in the need for further research
and studies based on screening practices o f primary care providers.
Eichler et al. (2015) identified some concerns in the study. First, screening could
result in potential harm. Older patients may avoid seeing their doctor for fear o f being
diagnosed with dementia; and, second, a false-positive screening could cause
misdiagnosis resulting in anxiety and depression in the affected patients. Discussion was
provided on future research including further implementation o f screening procedures for
differential diagnoses.
Eichler et al. (2015) was included in this literature review for the present research
on cognitive impairment screening practices of primary care providers in Mississippi in

that the analytical results indicated that a considerable number of patients that do have
some degree o f cognitive impairment are not being recognized based on primary care
visits where a screening tool is not used. The results provided evidence that routine
screening can help to increase the diagnosis rate of dementia considerably which will
lead to better outcomes for many patients. The significance of this study related to the
current study in that it is concerned with the problem that dementia and Alzheimer’s
disease goes unrecognized in a large number o f patients while under the care of a primary
care provider. The present study was guided by Neuman’s Systems Model which focuses
on the client as a whole system.
Fowler et al. (2012) used a cross-sectional design to determine patients’
perceptions and willingness to undergo screening for dementia in primary care settings.
Over 4 million Americans are affected by dementia which is an incurable degenerative
neurological disease. The United States Preventative Services Task Force recommends
there is no evidence to uphold the screening for dementia by primary care providers
because o f insufficient evidence to support if screening is beneficial, harmful, or
effective. The goal o f Medicare annual visits is to prevent disease, and one of the nine
elements consists o f cognitive impairment screening. Patients’ perceptions o f cognitive
screening may be viewed as harmful or beneficial, while gathering data to grasp patients’
thoughts of dementia screening may reflect the outcome goals of wellness screenings by
primary care providers. No theoretical framework was identified in this study.
The hypothesis o f Fowler et al. (2012) was to determine the relationship between
patients’ perceptions and their readiness to be evaluated for dementia. The proposed
explanation was that patients who viewed harm in being screened were more likely to
refuse screening versus individuals who viewed screening as beneficial. The Perceptions

Regarding Investigational Screening for Memory in Primary Care Questionnaire
(PRISM-PC) designed by researchers at Indiana University Center for Aging Research
was an instrument utilized in the initial screening process to capture viewpoints of
individuals’ perceptions of dementia screening.
Participants aged 65 years and older with no documented diagnosis o f dementia
were approached by research assistants from the Indiana University Practice Based
Research Network between January 2008 and June 2009. The selected participants
received healthcare services from a primary care community-based system in
Indianapolis, IN. Study participants signed an informed consent. The PRISM-PC
domains consisted of the following: (a) acceptance o f dementia screening, (b) benefits of
dementia screening, (c) stigma of dementia screening, (d) negative impact o f dementia
screening on independence, (e) suffering related to dementia screening, (f) screening for
other conditions, and (g) beliefs related to treatment for Alzheimer’s disease.
After completion o f the PRISM-PC, 89.7% o f participants agreed to undergo
screening for dementia by a written test. The MMSE or the Community Screening
Interview for Dementia (CSI-D) was given to each individual. O f the 497 (89.7%)
initially screened, 63 (12.7%) screened positive for impaired cognition. The analysis
proved that the only significant variance of accepting or declining screening was in the
age range. Ages 70-79 years was the age range most likely to decline screening due to
loss o f autonomy. They were also the age range that would mostly benefit from
screening.
The results o f this study established that most of the participants were willing to
be screened for dementia. The refusal rate was higher in individuals aged 70 to 79 years
old. PCPs should be educated about the prevalence of the refusal in this age range.

Education to this age group will allow the patients a clearer understanding of the
available interventions to decrease or prevent cognitive impairment. Interventions PCPs
may include in their assessment for prevention or treatment of cognitive impairment
include the following: (a) eliminating certain medications that increase the risk for
cognitive impairment (e.g., Oxybutynin), (b) checking labs such as Vitamin D (as we
know that low vitamin D levels increase plaque formation in the brain), and (c)
completion o f dementia screenings at a younger age are
Coutinho, Drummond, Teldeschi, and Mattos (2016) attempted to determine if the
level o f awareness regarding memory deficits is helpful in distinguishing between
depression and cognitive impairment. Inaccurate reports of memory loss or cognitive
status is a major challenge for memory clinics. Clients tend to overestimate or
underestimate their own cognitive status, thus creating inaccuracies. Therefore, it is
important to determine if a client is suffering from major depressive disorder (MDD)
before a diagnosis o f mild cognitive impairment (MCI) is made. Discriminating the
differences between cognitive concerns and a true cognitive decline is essential in
diagnosis and treatment o f cognitive impairment. No theoretical framework was
identified for this study.
Coutinho et al. (2016) attempted to determine if there is a difference in personal
cognitive assessment between those with MDD and those who do not suffer MDD. In
addition, the question o f whether one group will perform better on the objective memory
testing was raised. The hypothesis o f the study was that clients with MDD would have
more complaints of memory loss than clients without MDD but would reveal normal
cognitive performance.

Coutinho et al. (2016) compared memory performance on objective testing, the
extent of memory complaints, and the level o f self-awareness o f memory deficits. O f the
63 patients, 38 were women and 25 were men. All participants were 61-86 years old
seeking evaluation because o f memory concerns. The subjects o f this study were
evaluated using the Geriatric Depression Scale (GDS) and the Mini-Mental State
Examination (MMSE) in a private memory clinic. All patients were diagnosed as either
MDD or MCI by a board-certified psychologist using the DSM-5 criteria. Those patients
without MDD or MCI diagnosis were used as a control group o f elderly with healthy
cognition. Age and years o f formal education were similar in all three groups. Direct
questioning about memory complaints and concerns were asked on a questionnaire to
determine a self-report of memory status. Subjects then performed the Rey Auditory
Verbal Learning Test (RAVLT) to determine actual cognitive impairment. Level of
awareness was calculated by self-reported memory appraisal versus performance o f the
RAVLT. To compare demographic, neuropsychological, and self-reported variables,
ANOVA testing was used. Effect size was determined by using eta squared. A 2-tailed
significance threshold was used for all statistical tests.
The level o f awareness between the MCI group and the control group did not
differ; however, the awareness between MDD and MCI subjects was significant. The
MDD subjects underestimated their memory functioning but performed well on their
memory testing. The MCI subjects overestimated their cognitive performance but scored
lower on their memory testing. This testing proves that depression can cause an
alteration in a subjective memory analysis. Therefore, self-report o f cognitive
impairment is not always reliable, and an objective memory test must also be performed.

Coutinho et al. (2016) provided a limited sample size, with more subjects in the
control group than in either of the groups being studied. There were 25 subjects in the
control group, only 16 in the MDD group, and 22 subjects in the MCI group. While the
data are still adequate, a larger sample size would enhance the relevance o f the study.
The researchers including educational background and age limits were necessary for
adequate comparison of subjects. It is also beneficial that the subjects did not know they
were performing in a research study, which could have altered or skewed the data.
While Coutinho et al.’s (2016) study does not directly relate to the current
research project, it was definitely a valuable resource. It is important to note that neither
the subjective nor the objective memory testing alone is an adequate tool to determine
MCI. The current researchers assessed data based on an objective memory test. In
addition to a practitioner performing an objective memory test, it was important to see if
a self-report memory test is completed as well.
Bayley et al. (2015) conducted a study with the purpose to report experience with
a large nationwide public memory screening program. The background and significance
o f the study were detection o f cognitive impairment being the first step for determining
whether an individual needs further assessment for significant memory disorder or
dementia. No theoretical framework was identified for this study.
The following research questions were not clearly stated in the study;
1. Is community-based screening a good tool for assessing cognitive
impairment?
2. Is this screening tool more or less effective in the community setting or
general practitioner's office?

3. Do age, gender, and education level play a comparative role in cognitive
impairment?
4. Should other factors such as family members and friends be involved in the
study?
The study was conducted in local community sites. The information compiled
for this report consisted o f 4,396 participants. O f these participants, 1,257 were male and
3,109 were female. The ages ranged from < 35years old to > 85 years old. Highest
education levels were elementary, high school, > high school, bachelor's degree, and
post-bachelor's degree. Races were White, Black, Hispanic, or other.
The participants volunteered for the study. Upon arrival to the site, participants
were given a voluntary participant survey with 29 questions which included the
following: (a) demographic characteristics, (b) medical history, (c) reasons for attending
the screening, (d) preferences for where to conduct the screening, (e) concerns of beliefs
about memory, and (f) their current activities to help reduce the risk for dementia. Each
site was set up to conduct one of the 7 well-validated dementia screening tools. The tools
were the Mini-Cog, General Practitioner Assessment of Cognition (GPCOG), Memory
Impairment Screen (MIS), Kokmen Short Test of Mental Status (STMS), Mini-Mental
State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and the Saint
Louis University Mental State Examination (SLUMS). These tools met the criteria for
screening. They were validated, easy to administer, no cost, relatively free o f education,
race, or cultural bias, and took 5 minutes or less to administer.
A private room was set up for each screener, and each test adhered to a standard
format. Each site was responsible for time and location of screenings, selecting the
appropriate healthcare professionals to obtain information, selecting their screening test.

distributing and collecting all data forms, emphasizing confidentiality, publicizing the
event, encouraging participants with screening scores below cutoff to follow up with their
healthcare provider, and distributing additional education material.
Overall, 11.7% failed one of the 7 screening tests. Failure rates were higher in
older and less-educated participants. Subjective memory concerns were associated with
40% greater failure rate for persons of similar age and education but no memory
concerns; 88.1% o f the participants were told that they did not have memory problems
detectable with the tests used. On the survey given before the screening, the question
"Are you concerned about your memory?" 11% answered no, with 8.2% failing the
screening. Because the individuals did not sign consent, data were collected
anonymously. Birthdates were not collected, and age was reported in broad 10-year
increments. Also, the study may have been more biased since participants were aware of
study beforehand and may have had concerns with memory loss. The scientists were
overall happy with this study; however, there were a few recommendations for future
studies. The first would be too involved third-party participation who were aware of
participants' levels of daily function. Secondly, the participants would be given a
tracking number for declines in scores over time to determine whether screening led to
appropriate support, education, and other resources. There would also need to be a way
to ensure that follow-ups were conducted with these patients and their primary healthcare
providers.
Holsinger et al. (2012) performed a study to determine specificity and sensitivity
o f four screening instruments used to detect cognitive impairments and dementia in
primary care. It has been predicted that the prevalence of cognitively impaired patients
will drastically increase in the elderly population in the coming years. A nationwide

study determined that 14% of those patients 70 years and older had dementia. Cognitive
impairment without dementia (CIND) and mild cognitive impairment accounted for 6%
to 22%; out o f those with CIND, 12% later developed dementia. Holsinger et al. (2012)
sought to pursue this study based on the prevalence o f missed or undiagnosed cognitive
impairment and dementia in primary care. No theoretical framework use was mentioned
in this study.
In finding that primary care providers wanted more information on the validity of
screening tools, Holsinger et al. (2012) took four screening tools and determined their
accuracy o f detecting cognitive impairments and dementia. The researchers wanted to
determine if the brief tools screened as well as longer tools. The modified Mini-Mental
State Examination (3MS), Memory Impairment Screen, Mini-Cog, and a two-item
functional memory screen were the tools studied. The 3MS and the Mini-Cog had the
highest accuracy o f detection in this study. The 3MS used in this study was a modified
version of the Mini-Mental State Exam. It was designed to better assess memory, verbal
fluency, similarities, and delayed recall (Holsinger et al., 2012). The Mini-Cog is a brief
screening tool used to assess memory and recall and uses the Clock Drawing Test.
The study was conducted using three primary care clinics o f veterans. There were
630 participants who were aged 65 years and older and had no previous diagnosis of
dementia or psychotic illness in their medical record. O f the 630 participants, most were
male with an average age o f 74.8 years. The participants were sampled at random in one
o f the three primary care clinics. A blinded research nurse performed the interviews and
provided the screening tools to participants. Medical history was also documented with
screening information, such as cardiac function, stroke, head injury, and substance abuse

(Holsinger et al., 2012). Previous findings have suggested that depression is associated
with dementia and was also evaluated with the study.
Holsinger et al. (2012) found that 21 participants met criteria for dementia and
247 for CIND. Dementia rates were lower than expected, but as assumed undetected
CIND was high. The longer 3MS screening tool was found to have the greatest accuracy
and proved 76% sensitivity and 88% specificity overall. However, because it takes
longer (17 minutes) to complete, it is not practical to use for screening in primary care
clinics. There was no difference in sensitivity between the Mini-Cog and the 3MS. The
Mini-Cog performed moderately well in the detection of dementia with 76% sensitivity
and 73% specificity. Screening is not diagnostic for diagnosis but prompts further
evaluation. Holsinger et al. recommended more testing and more information from
participants be gathered regarding medical record review to more accurately diagnosis
cognitive impairment.
Holsinger et al. (2012) chose participants > 65 years old at random during
screening interviews. A strictly demented or cognitively impaired population was not
used, and a blinded research nurse performed the screening so that bias could be reduced.
Using veteran clinics and with the majority of participants being male, results cannot be
generalized as well to women. Similarly, a small range of dementia participants could
skew test sensitivity in testing for dementia. Also, veterans often tend to have high
education and could limit generalizability (Holsinger et al., 2012).
The current research evaluated use o f screening tools to detect cognitive
impairment and dementia in primary care clinics. The screening tools used were the
Mini-Mental State Examination, Mini-Cog, and The Clock Drawing Test. The current
researchers assessed whether providers are using these tools on patients older than 65

years. Interestingly, Holsinger et al.’s study also used a population o f 65 years or older
and used the Mini-Mental State Exam and the Mini-Cog. These two screening tools
proved to be most accurate in their study.
Fowler et al. (2015) performed a study to examine the relationship between older
primary care patients’ attitudes about dementia screening and their behavior toward
diagnostic assessments after a positive dementia screening. Understanding the
importance o f why patients agree or disagree to diagnostic assessment after screening
positive is critical. It is estimated that 5.3 million Americans have dementia, and 50% o f
these are never diagnosed. This proposes a major challenge for healthcare providers and
has devastating effects on patients and their families. The stigmas surrounding cognitive
impairment screening and subsequent dementia diagnosis could be associated with the
high rates o f undetected cognitive impairment which leads to patients not receiving the
potential benefits o f earlier recognition. No theoretical framework was mentioned in this
study.
Fowler et al. (2015) identified the hypothesis that patients between 70 and 80
years old would be more likely to refuse diagnostic assessment. Another hypothesis was
that patients who acknowledged the benefits o f early detection would be more likely to
accept a follow-up evaluation after screening positive for cognitive decline.
The study population was recruited from a healthcare system known as Eskenazi
Health in Indianapolis. The participants were 65 years or older and did not have a
documented diagnosis o f dementia at the time o f recruitment. A total o f 1,065 patients
were asked to participate. O f the 1,065 participants, 550 agreed and signed informed
consent to participate. Perceptions about dementia screening and diagnosis were
obtained through personal encounters and measured with a questionnaire known as the

Perceptions Regarding Investigational Screening for Memory in Primary Care (PRISMPC). The PRISM-PC questionnaire is composed of 50 items which examines the
perceived harms and benefits of screening for dementia. Twelve items capture
sociodemographic data and the study participants’ experiences with Alzheimer’s disease.
The 38 remaining items measure participants’ perceptions of and attitudes about the
acceptance, benefits, and harms of dementia screening and were scored on a 5-point
Likert scale. Participants were asked to complete the PRISM-PC and then were asked
about willingness to be screened for memory problems. Community Screening
Instrument for Dementia (CSI-D) and the Mini-Mental State Examination (MMSE) were
used for memory problem screening (Fowler et al., 2015).
Reverse-coding was performed on the PRISM-PC before analysis so that a higher
score indicated stronger agreement with the items. This is done to conduct psychometric
analyses and predict validity. The Fisher exact test was used for categorical variables and
the two-sample t test for continuous variables to compare demographics and PRISM-PC
domain scores. Logistic regression was used to model the association of the PRISM-PC
domains and demographics with the refusal of diagnostic assessment. O f the 554
participants that completed the PRISM-PC questionnaire, 497 participants agreed to
dementia screening. Sixty-three of the 497 participants screened positive and were
referred for a diagnostic assessment. Among the 63 participants that were referred for an
evaluation, 21 participants agreed and went on to complete the diagnostic assessment.
The 42 participants remaining refused follow-up assessment. Among the participants
screening positive, 61.9% were female, 55.6% were African Americans, 48% were
widowed, and 48% lived alone. O f the 42 participants that refused diagnostic
assessment, 25 participants lived alone and 33 participants were below 80 years of age. It

is worth mentioning that those who refused diagnostic assessment agreed more with
statements pertaining to stigmas related to dementia on the PRISM-PC than those who
agreed to further assessment for dementia.
Limitations o f this study by Fowler et al. (2015) included its small sample size;
however, despite the sample size, several relationships were statistically significant.
Another limitation was the lack of ability to track those patients that screened positive to
ascertain if they sought further medical treatment. The findings o f Fowler et al. (2015)
are important as it is known that the detection o f cognitive impairment and dementia rates
are low and patients that are cognitively impaired are not receiving the interventions and
education that could possibly address the perceived stigmas associated with cognitive
screening and diagnostic assessment.
Intervening on behalf of patients with possible cognitive impairment or dementia
and changing the stigmas associated with these could potentially increase the number of
patients becoming more receptive to cognitive impairment screening and diagnosis of
dementia. In a study that is seeking to determine if primary care providers in Mississippi
are screening for cognitive impairment, the current researchers hope to elucidate common
practices that focus on the detection and diagnosis o f cognitive impairment. The
prospective gain in studying the screening practices of primary care providers is to help
ensure that patients with possible cognitive decline do not go untreated. Examining the
relationship between older patients’ perceptions about cognitive screening for dementia
and their behavior toward a diagnostic assessment after a positive screening could help in
designing a more holistic approach in caring for patients. Early intervention through
education on cognitive impairment would potentially address the perceived stigmas
associated with a dementia diagnosis. The Health Promotion Model was used to guide

the study on the screening practices of PCPs in Mississippi. Oe of the theoretical
assertions o f this model is that patient self-efficacy will increase as the negative
perceived perceptions o f an illness are decreased. As determined in the present study,
providing education to older patients on the importance of early detection o f cognitive
impairment through screening could help break the barriers associated with the diagnosis
o f any dementia-related disease.
Summary
All of the previous information that was gathered to support the basis o f the
current research project was utilized to form the tool to determine whether or not
healthcare providers are using a screening tool for cognitive impairment. If so, which
one are they using; if other labs, comorbidities, past medical history, and medications are
pertinent to the evaluation and prevention o f cognitive decline.

CHAPTER III
Design and Methodology
The purpose of this study was to determine whether primary care providers are
following the American Alzheimer’s Association guidelines related to cognitive
impairment screening during an annual wellness visit that was put into place by the
Patient Protection and Affordable Care Act o f 2010 effective January 1, 2011. This
chapter provides information regarding the design, setting, population, sample, method of
data collection, and data analysis of retrospective chart reviews utilized to conduct this
study.
Design of the Study
A descriptive, retrospective chart review was the design used in this study.
Retrospective review was suitable for this study because information from patient charts
is needed to determine if primary care providers are following the guidelines of the
American Alzheimer’s Association on annual cognitive impairment screening.
Setting for Research Project
The retrospective chart reviews took place in 6 primary care clinics. The clinics
were in rural and urban areas o f north and central Mississippi. These clinics employed
both physicians and nurse practitioners, and charts were chosen at random based on
Medicare patients over 65 years old.
Population and Sample
A convenience sample was utilized for this study. The population o f the study
included men and women aged 65 years and older and on Medicare. This population was
relevant to the study in that the older population develops cognitive impairment and
should be screened for such. The Patient Protection and Affordable Care Act requires

that screening be done during an annual wellness visit in patients 65 years and older
which validates using this specific population. Six-hundred patient charts were reviewed
for screening, 100 from each o f the 6 clinics. The patients included in this study were
from various cultural and racial groups.
Methods of Data Collection
After obtaining approval from the Institutional Review Board (IRB) (see
Appendix A), the research was collected using a data collection tool to easily compile
patient information for statistical analysis. Before collecting information, a consent
document was reviewed and signed by the office managers of the primary care clinics
(see Appendix B). This consent was necessary to protect the privacy of patients and
informed the clinic that findings o f the research would be reported back to them if
desired. Researchers went into the clinic during normal business hours and reviewed 100
patient charts with the oversight o f the office manager over a 4-week period in the Spring
of 2017. The data collection tool was used to compile information pertaining to general
demographics (e.g., age, sex, race, and ethnicity), and patient history including
documentation of kidney function, hypertension, diabetes, vitamin deficiency, current
medications, falls, and tobacco use (see Appendix C). The overall goal of the collection
tool was to evaluate if healthcare providers assessed cognitive function in those 65 years
and older.
Methods of Data Analysis
Data were subjected to analysis and then were reported using means and standard
deviations to describe the findings of providers screening for cognitive impairment.
Percentages were used to report healthcare providers’ compliance with current national
guidelines. Chi-square analyses were used to derive additional data regarding relations of

chronic disease and cognitive impairment based on documented history o f the patient.
Data obtained reflected the providers’ adherence to the recommended national guidelines
regarding the screening of cognitive impairment. Results can be used to demonstrate to
providers how significant screening and early detection are for cognitive impairment.

CHAPTER IV
Research Findings
The purpose o f the study was to identify if primary care providers practicing in 6
rural community-based clinics in Mississippi were screening for cognitive impairment.
The USPSTF recommends cognitive impairment screening for all patients 65 years and
older. Prompt detection will allow providers to put preventative practices in place, such
as therapies and/or medication regimes, to slow the effects o f cognitive impairment.
Additional research was reviewed to determine the appropriate screening tool(s) to use in
collecting data. Furthermore, the researchers sought to determine what intervention was
indicated for patients who showed a decline in cognition on the screening tools.
Profile of Study Population
Data from the current research were obtained by reviewing a convenience sample
of 100 charts at each o f the 6 clinics. The sample included any patient 65 years and older
obtaining a Medicare wellness visit while at the clinic. Data were manually extracted and
recorded on a data collection worksheet. Demographic data included age, race, gender,
marital and education status, and housing. The researchers recorded if cognitive
screening was performed; and, if performed, what cognitive screening test was used.
Furthermore, if any patient treatment or interventions were initiated due to screening
results, those were documented as well.
A convenience sample o f 600 medical records {n = 600) 65 years and older was
obtained from 6 separate primary care clinics in Mississippi from February-March 2017.
All o f the patients fell within this age group as stated by the Affordable Care Act. The
sample o f 600 patients included 55.6% female patients {n = 330) and 43.8% of male

patients {n = 263). No gender was reported in 1.2% (/? = 7) of patients. The researchers
assessed the race of the participants. African Americans comprised of 19.8% {n = 119)
o f the population studied, while 74.8% {n = 449) o f the participants were white. Other
was reported for 0.8% (n = 5) of participants with 27 surveys with no race reported
Education was determined by years o f formal education. Less than 12 years of education
was obtained by 15.5% (n = 93) of the participants, while 10.5% (n = 63) had 12 or more
years of formal education. O f the 600 participants, 74% (n = 444) o f the charts did not
have educational level recorded. The researchers recorded the living status o f the
participants. O f the 600 charts that were reviewed, 62.7% (n = 376) patients do not live
alone, while 27.7% (n = 166) of the patients live by themselves. In addition, 1.3% (n =
8) participants resided in a skilled facility, while 8.3% (n = 50) of charts did not report
housing for the participants. The marital status of the participants was recorded by the
researchers. O f the 600 participants, 49.7% {n = 298) were married, 15% (n = 90) were
divorced, 25% (n = 150) were widowed, and 2.5% (/? = 15) were never married. Marital
status was not documented for 7.8% (n = 47) of the participants.
Statistical Results
A total of 600 charts for patients 65 years and older presenting to the clinic for an
annual wellness visit were chosen for a retrospective chart review. The wellness visits all
occurred after January 1, 2011, when the recommendation by the Affordable Care Act
included cognitive screening. The researchers compiled and organized the data using the
data collection worksheets. Data were entered on a Microsoft Excel spreadsheet. A
professional statistician analyzed the data using IBM SPSS statistical software, version
22. Analyses were performed to answer the research questions. The following questions
were investigated by the researchers.

Findings Related to the Research Questions
Research question 1. During annual wellness visits, are primary care providers
screening Medicare patients 65 years and older to detect cognitive impairment? See
Figure 1.

Figure 1. Screening test performed during annual wellness visit.

Research question 2. During the cognitive impairment screening, are primary
care providers using one of the three validated patient assessment tools: the General
Practitioner Assessment of Cognition (GPCOG), the Memory Impairment Screen (MIS),
Mini-Mental State Exam (MMSE), or the Mini-Cog when cognitive impairment
screening is performed? If none o f the above, which assessment tool are they using? See
Figure 2.

Figure 2. Screening tools used in the research study.

Research question 3. What interventions are put into place for patients who show
a decline in cognition on these screening tools? See Figure 3.

Note. The plan o f care im plem ented in the single case was m edication for dementia.

Figure 3. Interventions for cognitive impairment.
Data Analysis
Data were collected from patient charts at 6 respective clinics located in northern
and central Mississippi and entered on a researcher-developed data collection tool. Data
were then entered into Microsoft Excel and analysis performed using IBM SPSS

statistical software, version 22, in an effort to accurately answer the three research
questions.
Data analysis revealed primary care providers were noncompliant in screening for
cognitive impairment. O f the charts reviewed, only 5 patients (0.8%) included a
cognitive test. O f the 5 patients whose record included a cognitive test, 3 (60%) used the
MMSE test, 1 (20%) used the Mini-Cog, and 1 (20%) did not report the test type. O f the
5 patients whose record included a cognitive test, 2 (40%) showed a cognitive
impairment. O f those 2, only 1 (50%) implemented a plan of care. The plan o f care
implemented in the single case was medication for dementia.
Summary Findings
Chapter IV presented the researchers’ findings from the current retrospective
chart review of 600 patients from the 6 rural clinics in northern and central Mississippi.
Findings from the demographics and medical history were comprised in figures for
comparison. The results o f this analysis revealed that primary healthcare providers were
not screening for cognitive impairment and were noncompliant with the
recommendations. There is a significant need o f improvement in diagnosing and
managing those with cognitive impairment. Due to the overall lack o f primary care
providers properly screening those for cognitive impairment, this study will provide an
outstanding opportunity to provide education to providers about the importance o f
screening practices. With adequate screening practices in place, the number of those who
are afflicted by the detrimental effects o f undetected cognitive impairment can be greatly
decreased.

CHAPTER V
Summary and Conclusions
This research study examined whether primary care providers were following
current recommendations for screening Medicare pav. According to the Centers for
Disease Control and prevention (CDC), over 16 million people in the United States are
living with cognitive impairment. The predominant risk factor for cognitive impairment
is advanced age. As America’s generation of baby boomers progress on into their senior
years, the number o f individuals suffering from cognitive impairment and related
complications is expected to increase dramatically. Unfortunately, cognitive impairment
goes unrecognized in 27% -81% o f affected patients in primary care (Cordell et al.,
2013).
Compliance was evaluated based on the following research questions:
1. During annual wellness visits, are primary care providers screening Medicare
patients 65 years and older to detect cognitive impairment?
2. During the cognitive impairment screening, are primary care providers using
one o f the three validated patient assessment tools: the General Practitioner
Assessment of Cognition (GPCOG), the Memory Impairment Screen (MIS),
Mini-Mental State Exam (MMSE), or the Mini-Cog when cognitive
impairment screening is performed? If none of the above, which assessment
tool are they using?
3.

What interventions are put into place for patients who show a decline in
cognition on these screening tools?

Researchers utilized Nola J. Pender’s Health Promotion Model as the theoretical
framework to guide the current research. Included in this chapter are the following: a

summary o f the findings, implications o f the results, and recommendations for additional
research.
Summary of the Findings
The initial sample consisted o f 600 patient charts. The charts were obtained from
6 primary care provider offices in the state of Mississippi. The charts o f Medicare
patients 65 years and older that had presented for their annual wellness visit were
selected. O f the charts that were selected for review, only 5 patients received a cognitive
impairment screening.
Patient demographies were extracted from each patient record. O f the 600
records evaluated, 55.6% (n = 330) were female patients, 43.8% (/? = 263) were male
patients, and 1.2% (n = 7) had no gender reported. All 600 patients were age 65 years or
older. Their ages were categorized as follows: 65-69 years (29.5%; n = 177), 70-74 years
(24.2%; n = 145), 75-79 years (24.2%, n = 145), and 80+ years (22.2%; n = 133). If the
number o f patients reported in a factor do not sum to the total sample size (600), the
remaining records did not have that demographic factor reported.
Discussion of the Findings
The researchers revealed that 5 or 0.8% o f the 600 patients were actually screened
for impairment in cognition. O f the 5 patients who were cognitively screened, 3 (60%)
used the MMSE test, 1 (20%) used the Mini-Cog, and 1 (20%) did not report the test
type. O f the 5 patients whose records included a cognitive test, 2 (40%) showed a
cognitive impairment. O f those 2, only 1 (50%) implemented a plan o f care. The plan o f
care implemented in the single case was medications for dementia.

Limitations of the Research
The following limitations of the research design and methods of data analysis
were identified at the conclusion o f the study:
1. The sites o f data eolleetion were limited to six primary care elinies in north
and central Mississippi.
2.

Limited sample size consisting o f 600 charts— 100 from each primary care
provider’s clinic.

The researchers obtained a limited sample size of 600 charts which diminished the
reliability o f the current research. The results obtained by the researchers from such a
limited sample size may not be indicative of all clinics screening practices across the state
of Mississippi. To increase the reliability o f the research findings related to provider
screening practices o f cognitive impairment, utilization o f a greater sample size
evaluating data from various clinics across the state would be beneficial.
Data collection was limited to primary care providers’ clinics located in the state
o f Mississippi. Restricting data collection to this one geographical location in the
southeastern United States may not best exemplify the screening practices across the
nation as a whole. Broadening the research to encompass other regions across the nation
would give a better indication of the number o f primary care providers that are following
the recommendations for screening for cognitive impairment across the United States.
Implications
Various implications were constructed following the conclusion of the current
research. Implications include providing an area o f focus for performance improvement
in the primary care setting. Findings from the current research suggest that primary care
providers are falling short o f the suggested guidelines of cognitive impairment screening.

Clinical practice. Early detection o f cognitive impairment is fundamental.
Detection of cognitive impairment in the early stages o f the disease process allows for
application o f interventions that may slow the progression o f cognitive impairment and
allow the patient to enjoy a better quality of life for an extended period o f time.
Interventions, such as management o f comorbidities and medications, can aid in slowing
the progression from mild cognitive impairment to detrimental diseases such as
Alzheimer’s and dementia.
By increasing primary care providers’ awareness o f the recommendations related
to screening for cognitive impairment during the annual wellness visit, the number of
patients properly screened for cognitive impairment can be increased. This increase in
screening would in turn result in early interventions decreasing the prevalence o f
advanced cognitive impairment-related illnesses.
Nursing education. The current research concluded that primary healthcare
providers are failing to adequately screen patients for cognitive impairment during the
Medicare annual wellness visit. This finding indicated that additional education is
required to emphasize the importance of screening patients who are at increased risk for
the development of cognitive impairment.
Primary care providers must take into account the importance of early detection
when it comes to screening patients for cognitive impairment. Early detection of
cognitive impairment is the key to catching the disease progression in its early stages
where interventions, such as cognitive therapy and pharmacological treatment, are most
beneficial. Though the absence o f cognitive impairment and the eradication of the
disease process may not be possible, the prolonging of the patient's cognition and his or
her overall quality o f life should be the goal.

The outcomes o f this research study confirms the deficiency of cognitive
impairment screening and early detection o f cognitive impairment taking place during the
Medicare annual wellness visits. The next course o f action as healthcare providers and
patient advocates should be to educate colleagues on the importance o f cognitive
impairment screening and the beneficial outcomes of early detection. Taking into
consideration that screening practices may vary for each provider, it is important to
encourage colleges to incorporate a recommended screening tools, such as the mini
mental exam that can be easily conducted during the screening process.
The offices o f the providers that participated in the current research will be
provided a copy of the research findings and results. The primary care providers can
utilize the information obtained from the research to implement a policy or procedure
within their clinic to increase the number of patients screened who are at risk for
cognitive impairment.
Nursing research. Evidence-based practices are brought about as the result of
well-designed and organized research. Recommendations for further research
possibilities can be suggested with the conclusion of this research. First, research should
be conducted that explores the reasons why primary care providers are not screening
patients for cognitive impairment. These reasons could include lack o f education
concerning the current guidelines. Consideration can also be given to the possibility that
consumers o f Medicare are not aware o f certain benefits afforded to them. Research can
be conducted to determine if Medicare beneficiaries are informed or understand these
benefits. Replication o f the current research using a larger sample and a more diverse
demographic range should be done to determine if cognitive impairment screening
practices are the same in other regions or are they specific to a certain area.

Nursing theory. Nola Pender’s Health Promotion Model was selected by the
researchers as the theoretical foundation for the current research. Pender believes the
patient should play an active role in managing his or her health by desiring to change or
alter certain lifestyles that may contribute to disease. Recognizing any perceived barriers
can be a positive step toward motivating the patient to accept a diagnosis o f cognitive
impairment without the fear or stigma related to changes in cognition. Nola Pender’s
view also included the concept that past behavior, cultural traditions, and family
traditions can impact a person's ability to engage in health-promoting behaviors. The
assumption that healthcare providers are part o f the patient's interpersonal environment
opens up a wide avenue that allows the practitioner to become personally involved with
the patient. Her HPM provides healthcare providers with a tool that helps them to
understand how the consumer can be motivated to attain better health (Alligood, 20141).
The results o f this study will aid in the development o f methods to assist the practitioner
in recognizing cognitive impairment as part of the patient’s health promotion and
prevention.
Conclusion
The purpose of this research was to determine if primary health care providers are
screening Medicare patients 65 years and older during their annual wellness visit for
cognitive impairment. The study further evaluated the presence o f comorbidities and
associated factors increasing a patient’s risk for cognitive impairment. According to the
results of this study, cognitive impairment screening is not being performed on Medicare
patients during annual wellness visits. Since cognitive decline can ultimately progress to
dementia or Alzheimer's dementia, it is imperative that healthcare providers detect
changes in the patient's cognition so that appropriate treatments can be initiated early in

the disease process. It was also found that other factors can contribute to changes in
mental status and cognition, such as medications, smoking. Vitamin deficiencies, and
chronic disease. Knowing the medical history o f their patients and performing the
necessary screening to detect certain deficiencies can assist primary care providers in
promoting the importance o f cognitive screening and relaying this knowledge to their
patients.
Recommendations
Based on the results o f the current research, the following recommendations were
made for primary care providers:
1. Increase providers’ compliance of screening patients for cognitive impairment
according to recommendations.
2. Educate providers on the recommended screening tools available for detection
o f cognitive impairment.
3.

Increase providers’ awareness o f comorbidities and risk factors that increase
the likelihood that a patient will develop cognitive impairment.

4.

Increase the public’s awareness of cognitive impairment and the need for
screening to detect cognitive impairment in its early stages.
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March 13, 2017

Dr. Sueanne Davidson
Mississippi University for Women
College of Nursing and Speech Language Pathologv
1100 College Street, MUW- 910
Columbus, Mississippi 39701-5800
Dear Dr. Davidson:
I am pleased to inform you that the members of the Institutional Review Board (IRB)
have reviewed the following proposed research and have approved it as submitted:
N am e o f S tudy:

Cognitive Screening Practices o f Primary Care
Providers in Mississippi.

In v estig ato r(s):

Andrea Branch, Hillary Clayton. C eleste Hardin,
Stephanie Hubbard, Andrea H uddleston, and
Lauren Turner
S ueanne D avidson

R esearch F acu lty/A dvisor;

1 wish you much success in your research.
Sincerely,

Thomas C. Richardson, Ph.D.
Provost and Vice President for Academic Affairs
TCR/tc
pc: Tammie McCoy, Institutional Review Board Chairman

We are graduate students in the Family Nurse Praetitioner program at Mississippi
University for Women in Columbus, MS. As a program requirement, we are eondueting
a retrospective chart review to assess whether or not primary care providers are screening
patients for cognitive impairment. Data collected will be from the medical records of
Medicare patients aged 65 years and older. From each chart, a series o f corresponding
data related to cognitive impairment risk factors will be recorded. We are requesting
permission to review medical records within your practice that meet these criteria. We
are aware of the great importance to maintain the confidentiality o f all information
collected from the medical records.
We agree to undergo or consent to any HIP?A requirements set forth by your practice
regarding patient privacy and confidentiality. The data collected from each chart will be
recorded per the Data Collection Tool to be kept on a confidential electronic flash drive
stored in a secure location, with access only to the researchers. The drive will be
destroyed per HIPPA guidelines at the termination of the research project. No clinic or
patient identifiers will be used in the study.
Your participation in this study is strictly voluntary. You may withdraw your consent
and participation in the study at any time. The result of the study will be available to you
upon completion and may be beneficial to your practice as a quality assurance measure.
If you have any questions concerning this study, please contact one o f the following
committee members: Andrea Branch (662-251-7459), Hillary Clayton (662-231-0869),
Celeste Hardin (662-983-8288), Stephanie Hubbard (662-542-8619), Andrea Huddleston
(662-643-8179), Lauren Turner (601-506-0869), or Dr. Sueanne Davidson, Committee
Chair (205-399-1433).
Sincerely,

Andrea Branch, Hillary Clayton, Celeste Hardin, Stephanie Hubbard, Andrea
Huddleston, and Lauren Turner

I have read the above letter o f consent and agree to the utilization o f this clinic for the
above mentioned research project. I understand that HIPPA regulations will be strictly
followed and the confidentiality of each chart chosen will be maintained. I also
understand that the results of the study will be made available to me at the end o f project.

Name and Title

Date
APPENDIX C
Data Collection Tool

Demographics

Age (years):

65-69

70-74

Sex:

Male

Female

Race or ethnicity:

___ White

Education (years):

___ 0-11

Housing:

>80

Other

Afriean American
___

Living

75-79

>

12

alone

Does not live aloneSkilled
_
facility

Marital status:

Married

Divorced

Widowed

Smoker:

Smoker

Nonsmoker

Never married

Polypharmacy (> 5 meds RX or OTC):
Labs within the last 3 years: ___ Vitamin D

B-12

GFR

Polypharmacy (> 5 meds RX and/or O T C ):___
Any opioid use?

Yes

No

Any NSAIDS use?

Yes

No

Currently taking anticholinergics?

Yes

No

Diagnosed with any o f the following?
Was cognitive test performed?
If yes, what test?

HTN
___ Yes

_
__

Diabetes
No

___ MMSE
Mini-Cog
GPCOG
MIS
Other

If cognitive impairment was detected, was a plan o f care implemented?
If yes, what was implemented?
Neuro referral

Depression

Social services

Yes

Medications for dementia

No

